Caulette Young - ScvO2 in the PICU: A Little Tool with Big Implications

1.	ScvO2 in the PICU: A Little Tool with Big Implications
2.	Caulette Young Speaker Profile
3.	Session Description
4.	Learning Outcomes
5.	Bibliography
6.	What is our main goal for patients in ICU?
7.	Using continuous ScvO2 monitoring
8.	Reflection Spectrophotometry
9.	ScvO2
10.	Factors to be considered in Oxygenation
11.	"Oxygen delivery does not provide information about the adequacy of tissue oxygenation."
12.	"Adequate" oxygenation can only be definied when tissue O2 supply matches tissue O2 demand
13.	Normal Oxygen Saturation
14.	Clinical practice paramaters
15.	Pediatric Septic Shock Recommendations with ScvO2 Monitoring
16.	Pediatric Original
17.	A Randomized Control Trial
18.	A Randomized Control Trial cont.
19.	A Randomized Control Trial cont.
20.	Target ScvO2 > 70% in goal-directed therapy, reduced mortality in sepsis

21.	AACM/PALS Guidelines For Pediatric Septic Shock
22.	Pediatric Special Article
23.	2007 ACCM Recommend Continued Updates to 2002 Guidelines for Pediatric Septic Shock
24.	ScvO2 Levels and Trends
25.	Has been considered a surrogate for cardiac output / index in pediatrics
26.	Mortality greatest in children with decreased cardiac output/index
27.	Mixed Venous Oxygen Saturation Monitoring After Stage 1 Palliation for Hypoplastic Left Heart Syndrome
28.	Predicting major adverse events after cardiac surgery in children
29.	Continuous central venous saturation monitoring in pediatrics
30.	Heart Rate per Hour
31.	Continuous central venous saturation monitoring in pediatrics
32.	ScvO2
33.	Factors in Percentage Increases in VO2
34.	Medications in Percentage Increases in VO2
35.	Anemia, Blood Loss, and Blood Transfusions in North American Children in the Intensive Care Unit
36.	ScvO2 in the PICU: A Little Tool with Big Implications

Caulette Young is a paid consultant of Edwards Lifesciences. Any quotes used in this material are taken from independent third-party publications and are not intended to imply that such third party received or endorsed any of the products of Edwards Lifesciences.

Early Goal-Directed Therapy and EGDT are trademarks of Dr. Emanuel Rivers.

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.